$STKO. NEWS ALERT: Stakool

New Post Public Reply Private Reply Replies (0) Message Board

Newer Older

goarmy123 mrbondz #116

Mar 14, 2012 at 10:08 PM

$STKO.

NEWS ALERT:

Stakool (OTCBB:STKO) in Prime Position as Wellness Bars Snatching Market from Diet and Athletic Bars

Wednesday, March 14, 2012

Stakool in Prime Position as Wellness Bars Snatching Market from Diet and Athletic Bars

With all of the dietary issues surrounding Americans, the health food industry is booming as consumers are continually looking to avoid processed foods and eat healthier. Leading cardiologist are frequently seen and heard on the television, online and in print, trumpeting the perils of bad diets that lead to heart disease, diabetes and other deadly illnesses. Showcasing the growth rate of the numbers of people looking to change their diets, the Organic Trade Association reported that U.S. sales of organic food and beverages have grown from $1 billion in 1990 to $26.7 billion in 2010. Sales in 2010 represented 7.7 percent growth over 2009 sales.

Furthermore, Americans “eat on the fly” more frequently than ever before and are gobbling snack foods to keep fuel in their tank in between (or sometimes in place of) meals. As such, sales nutritional snack bars have been steadily growing. According to data late last year from market research firm Symphony, dollar sales of snack bars/granola bars totaled $3.27 billion in the 52 weeks ended Oct. 30, 2011; an increase of 7% from the same period a year prior.

Combining the best of both worlds in a quest to capture the lion's share of the market in the future is Jacksonville, Florida-based Stakool Inc. (OTCBB:STKO). Through its wholly-owned subsidiary, Anthus Life Corp., Stakool is committed to being a leading North American supplier of natural and organic and health and wellness products by fulfilling the highest standards for quality, consistency, sustainability, product assortments, value-added support services and integrity in business and personal relationships. Natural plus Energy™ is the flagship brand under Anthus Life Corp.'s umbrella of expanding product lines.

The face of Natural plus Energy™ is 7-time Olympic Medalist Shannon Miller, a spokeswoman who personifies grace and health; building a strong brand awareness for the Anthus' products.
Stakool's prescient moves to sign-on Miller and aggressively market their wellness bars are coming at a perfect time. Nutraceuticals World published an article in January stating that, “diet bars are falling out of favor, wellness bars are on the rise and athletic bars are declining. In actuality, wellness bars are stealing market share from diet bars and athletic bars.” This fact bodes well for Stakool and Anthus.

Building upon that momentum on the corporate front, Stakool has taken steps in building shareholder value by lowering their outstanding share count by 110 million, expanding their market outreach through e-commerce platforms on online availability and taking an active role in traditional-style marketing through sponsorship of gymnastic events. Moreover, Stakool has tapped into the corporate catering market for sales growth through a new relationship with one of LasVegas' premier resorts, Red Rock Resort.

Expanding its revenue stream, the company has also struck a deal with iconic brand New Sun Cookies. The bi-lateral agreement will give the Natural plus Energy™ product line deeper market penetration as the two companies share distributors and combine product offerings, a win-win situation for both.

Last month, the company broadened its national footprint as Anthus Life Corp.'s product line was accepted by a national retailer with nearly 500 stores that caters to family, women and children with a wide array of quality lifestyle products. Initially, annual sales revenue from this one retailer is anticipated to reach $500,000, according to the company.

With the reduction in shares recently, STKO is left with only 74,604,667 shares equating to an unbelievably small market cap of under $900k. Expected revenue from the latest distribution deal could cover more than half of that by itself. In all fairness, Stakool is just now starting to turn the corner towards profitability and still operating at a minor loss as shown in its latest quarterly filings. But, positive things have happened to its capital structure and an increase in sales appears imminent, leaving substantial headroom for the stock to climb back north. After all, it was trading at 22 cents per share just four months ago.

Lending technical credence to a potential rise in share value is the STKO chart, which appears to be finding its bottom with a solid support level now established at the 1 cent mark. Key indicators such as the MACD and RSI are showing strength to trend and momentum as the stock pushed upward again today by 9.09% to close at $0.012. Heavier resistance won't enter the chart until 3 cents.

For most up-and-coming companies, finding the niche and an industry that can shepherd growth can be a daunting task, much less bringing a product to commercialization stages. Stakool, looks to have found its mark and is actively growing its reach while lowering its share structure; two important keys to building value. The fundamentals exude growth potential as well as the technicals, which should start putting STKO firmly on the radar of the investment community.

Rogue One Inc (ROAG) Stock Research Links

ROAG Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WIN Expands Global Family Support to 124 Countries

WIN's Ambitious Global Expansion In the ever-twisting labyrinth of corporate benefits, WIN is stepping up its game. We're talking an expansion that balloons past traditional fertility offerings into a global medley of support services covering every conceivable family and health scenario. It ain’t just about making babies anymore. When you're dealing with 124 countries,...

Protalix Unveils Promising Gout Therapy Data at ACR 2026

A Glimmer of Hope for Gout Sufferers Uncontrolled gout patients may soon see a light at the end of the tunnel. Protalix BioTherapeutics (NYSE American: PLX) just rolled out data at the ACR Convergence 2026, underscoring the potential of their drug candidate, PRX-115. This revelation is a big deal for those grappling with gout that just won't quit, constantly pelted by...

Xiaomi's Smart Auto Factory Draws Global Media Praise

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

EICMA 2026: Groundbreaking Moves in Two-Wheel World

Revving Up in Milan: A Record-Breaking EICMA If you're into two-wheelers as much as stocks, EICMA 2026 is where all the action is happening. They opened the door with a bang at Fiera Milano Rho, pulling off their biggest showcase yet. Ten halls packed to the brim, up from nine the previous year, creating buzz across the globe. Showcasing 765 exhibitors and 2,142 brands...

New Leadership at Reactive Tech: Claudio Facchin Steps In

Facchin Joins Reactive Technologies: Power Play or Predictable Move? Let me tell you, the energy sector ain’t for the faint-hearted—especially when you’re talking grid stability. Reactive Technologies just tossed an ace on the table, appointing Claudio Facchin as the new Board Chairman. If you've been around the block, you might recognize Facchin's name from his...

Leatt Gears Up for Q3 Results Conference Call

A good heads-up, folks, isn't just about keeping helmets snug—it’s about knowing when to cash in, especially when Leatt Corporation's got their Q3 results ready to drop. November 12 is the big day, so circle that on your calendars. They're rolling out the numbers before the market even gets its coffee, possibly nudging the ticker, OTCQB:LEAT, in a ripple you’ll want...

Target Hospitality's Growth and Earnings Analysis Q3 2026

Strategic Transformation: A Mixed Bag of Results In the raucous world of high-stakes business, folks, Target Hospitality Corp. (NASDAQ: TH) is making quite the noise. For Q3 2026, they trumpeted a juicy $129.1 million in revenue, which is a solid notch up by 30% from a year before. Yet, like a seasoned trader facing a knife-edge call, they're handling a bittersweet...

Energenesis Tackles Space Anemia with ATP Boost

Gearing Up for Space Medicine: Enter Energenesis With the cosmic frontier drawing investor eyes and day-to-day operations inching skyward, here comes Energenesis Biomedical (TWSE: 6657), poking its head into space medicine. This isn’t just another biotech firm looking to throw drugs at terrestrial problems. No, Energenesis shot its shot at TASTI 2026 with its...

Veterinary Stories Transform Pet Care in New Docuseries

Peeling Back the Scrubs: Hidden Heroes in Vet Medicine Everyone's all-hands-on-deck when it's your furball on the line, but how much do you really know about what happens in those vet offices? Finally, National Veterinary Associates (NVA) is unzipping that mystery with a no-bones-about-it docuseries, Advancing Veterinary Medicine: Our Stories, right out of Austin, Texas....

Zabalafin Hydrogel: Promise in Treating Atopic Dermatitis

Pioneering a New Path in Dermatology Treatment In the world of dermatology, finding a topical solution that tackles the full spectrum of atopic dermatitis (AD) is as rare as hens' teeth. But here's a twist—in a recent research paper gracing the Journal of Drugs in Dermatology, Alphyn Biologics sheds light on their unique contender, Zabalafin Hydrogel. This ain't your...